Literature DB >> 5344610

Unsuitability of leucine naphthylamide for the histochemical demonstration of lysosomal proteolytic activity.

A J Barrett, A R Poole.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5344610     DOI: 10.1038/224279a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Human skin proteases. Separation and characterization of two acid proteases resembling cathepsin B1 and cathepsin D and of an inhibitor of cathepsin B1.

Authors:  J E Fräki
Journal:  Arch Dermatol Res       Date:  1976-06-21       Impact factor: 3.017

2.  Evaluation of histochemical observations of activity of acid hydrolases obtained with semipermeable membrane techniques: a combined histochemical and biochemical investigation 1. The histochemical investigation.

Authors:  A E Meijer; D E Israël
Journal:  Histochemistry       Date:  1978-08-15

Review 3.  Lysosomal enzymes and inflammation with particular reference to rheumatoid diseases.

Authors:  J Chayen; L Bitensky
Journal:  Ann Rheum Dis       Date:  1971-09       Impact factor: 19.103

4.  The histochemical demonstration of hydrolytic enzymes in adjuvant-induced arthritis in rats.

Authors:  A D Pearse
Journal:  Histochem J       Date:  1974-07

5.  Studies on the soluble and membrane-bound amino acid 2-naphthylamidases in pig and human epidermis.

Authors:  G M Gray; A Tabiowo; M D Trotter
Journal:  Biochem J       Date:  1977-03-01       Impact factor: 3.857

6.  Human cathepsin B1. Purification and some properties of the enzyme.

Authors:  A J Barrett
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

7.  Cathepsin D. Purification of isoenzymes from human and chicken liver.

Authors:  A J Barrett
Journal:  Biochem J       Date:  1970-04       Impact factor: 3.857

8.  Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates.

Authors:  A J Barrett
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.